Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease
Lung cancer (LC) and chronic obstructive pulmonary disease (COPD) are among the
leading causes of mortality worldwide. Cigarette smoking is among the main aetiologic …
leading causes of mortality worldwide. Cigarette smoking is among the main aetiologic …
The association between a decrease in on-treatment neutrophil-to-eosinophil ratio (NER) at week 6 after ipilimumab plus nivolumab initiation and improved clinical …
Simple Summary Immune checkpoint inhibitors (ICIs) have significantly changed the
treatment paradigm in metastatic renal cell carcinoma (mRCC) and brought an …
treatment paradigm in metastatic renal cell carcinoma (mRCC) and brought an …
Sex differences in presentation, treatment, and survival in patients receiving palliative (chemo) radiotherapy for non-small cell lung cancer
C Nieder, SG Aanes, A Dalhaug… - Anticancer …, 2024 - ar.iiarjournals.org
Background/Aim: The aim of this study was to analyze sex differences in a real-world cohort
of patients who received palliative thoracic radiotherapy or chemoradiotherapy for non-small …
of patients who received palliative thoracic radiotherapy or chemoradiotherapy for non-small …
Fecal microbiome extract downregulates the expression of key proteins at the interface between airway remodelling and lung cancer pathogenesis in vitro
Lung cancer (LC) is the leading cause of cancer-related mortality, and it is caused by many
factors including cigarette smoking. Despite numerous treatment strategies for LC, its five …
factors including cigarette smoking. Despite numerous treatment strategies for LC, its five …
Development of novel small antitumor compounds inhibiting PD-1/PD-L1 binding
Y Akiyama, T Ashizawa, A Iizuka, T Ando… - Anticancer …, 2022 - ar.iiarjournals.org
Abstract Background/Aim: Anti-programmed death-1 (PD-1)/PD-ligand 1 (PD-L1) antibody is
a successful treatment for patients with solid cancers; however, there are several …
a successful treatment for patients with solid cancers; however, there are several …
In Vivo Antitumor Activity of the PD-1/PD-L1 Inhibitor SCL-1 in Various Mouse Tumor Models
T Ashizawa, A Iizuka, A Kanematsu, T Ando, C Maeda… - in vivo, 2025 - iv.iiarjournals.org
Background/Aim: Immune checkpoint blockade has achieved great success as a targeted
immunotherapy for solid cancers. However, small molecules that inhibit programmed death …
immunotherapy for solid cancers. However, small molecules that inhibit programmed death …
Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI)
T Tamura, T Numata, H Yanai, R Nakamura… - Anticancer …, 2023 - ar.iiarjournals.org
Background/Aim: Atezolizumab, an anti-programed death-ligand 1 monoclonal antibody,
targets programed death-ligand 1 expressed on cancer cells and antigen-presenting cells …
targets programed death-ligand 1 expressed on cancer cells and antigen-presenting cells …
Adverse Event Profile of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel Combination Therapy Based on JADER
K Endo, H Tanaka, H Matsuo, T Onoda… - Anticancer …, 2024 - ar.iiarjournals.org
Background/Aim: There have been advances in the development of immune checkpoint
inhibitors for monotherapy and combination therapy with other anticancer agents in recent …
inhibitors for monotherapy and combination therapy with other anticancer agents in recent …
Say 'No'to Cancer and 'Yes' to Cranberry: The Role of Cranberry Extract in Inhibition of Growth of Lung Adenocarcinoma Cells
L Zhao, E Kaser, M Lequio, K D'MELLO… - Anticancer …, 2023 - ar.iiarjournals.org
Background/Aim: Lung cancer is the leading cause of mortality due to cancer death.
Treatment of lung adenocarcinoma (LUAD) is still challenging. Cranberries contain many …
Treatment of lung adenocarcinoma (LUAD) is still challenging. Cranberries contain many …